Yes, absolutely pretreat with aspirin and a P2Y12 inhibitor (clopidogrel or ticagrelor) immediately upon presentation in NSTEMI.
Non-enteric-coated, chewable aspirin (162-325 mg) should be given to all NSTEMI patients as soon as possible after presentation, followed by a P2Y12 inhibitor loading dose, regardless of whether you're planning an invasive or conservative strategy 1.
Aspirin Administration
- Give non-enteric-coated aspirin 162-325 mg immediately upon presentation 1
- Continue maintenance dose 81-325 mg daily indefinitely 1
- Enteric-coated aspirin should be avoided initially due to delayed absorption 1
- If aspirin allergy exists, substitute with clopidogrel alone 1
P2Y12 Inhibitor Selection
The choice depends on your management strategy:
For Early Invasive Strategy (planned catheterization):
Preferred options before or at presentation:
- Ticagrelor 180 mg loading dose (Class IIa recommendation - reasonable to choose over clopidogrel) 1
- Clopidogrel 300-600 mg loading dose 2
At time of PCI (if anatomy known):
- Prasugrel 60 mg can be given once anatomy is defined and PCI is proceeding 2
- Do NOT give prasugrel before knowing anatomy if CABG might be needed 2
For Conservative/Ischemia-Guided Strategy:
- Clopidogrel or ticagrelor loading dose should be added to aspirin as soon as possible after admission 2
- Continue for up to 12 months 2
Critical Evidence Points
The 2014 AHA/ACC guidelines provide Class I (strongest) recommendations for immediate dual antiplatelet therapy in NSTEMI 1. The most recent 2025 ACC/AHA guidelines reinforce that ticagrelor plus aspirin is preferred for PCI and should be initiated early 3.
Important caveat about prasugrel pretreatment: The ACCOAST trial specifically showed that prasugrel pretreatment (before knowing coronary anatomy) in NSTEMI increased major bleeding without reducing ischemic events 4. Therefore, prasugrel should only be given at the time of PCI once anatomy is defined, not as pretreatment 2.
Maintenance Therapy
- Continue dual antiplatelet therapy for at least 12 months 1
- Aspirin dose with ticagrelor should be 81 mg daily (not higher doses) 1
- With clopidogrel, aspirin can be 81-325 mg daily 1
Common Pitfalls to Avoid
- Don't wait for catheterization to start antiplatelet therapy - benefits emerge within 24 hours 5
- Don't use prasugrel as pretreatment - only give after anatomy is known and PCI is planned 2, 4
- Don't use enteric-coated aspirin initially - absorption is too slow 1
- Don't give prasugrel if prior stroke/TIA - contraindicated due to increased intracranial bleeding risk 2
- Don't use high-dose aspirin (≥160 mg) maintenance with ticagrelor - increases bleeding without benefit 1
The evidence strongly supports immediate pretreatment in NSTEMI, as the antiplatelet effect begins within hours and reduces mortality, particularly with clopidogrel 6, 7. The FDA labeling for clopidogrel explicitly indicates its use in NSTEMI with or without planned revascularization 5.